Trials / Recruiting
RecruitingNCT06903975
BoTox Into the Sternocleidomastoid Muscles (SCM)
The Effect of Injection of prabotulinumtoxinA-xvfs (Jeuveau) Into the Bilateral Sternocleidomastoid Muscles on Neck Circumference and Aesthetics
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Boston Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.
Detailed description
The specific study objectives are to determine if: * the neck circumference is decreased at 4 weeks after botulinum toxin (prabotulinumtoxinA-xvfs) injection. * patients can appreciate a difference in their neck contour, self-confidence, and the way they perceive themselves post-injection via an aesthetics outcome and a neck perception survey. * injection of the botulinum toxin into the sternocleidomastoid muscle is safe to perform based on adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prabotulinumtoxinA-xvfs | Each participant will receive 60 units (U) of prabotulinumtoxinA-xvfs into each SCM for a total of 120 U. Participants will return in 2 weeks to determine if any touch-up injection is needed. |
Timeline
- Start date
- 2025-05-14
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-04-01
- Last updated
- 2026-04-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06903975. Inclusion in this directory is not an endorsement.